217 related articles for article (PubMed ID: 1823048)
1. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
2. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
[TBL] [Abstract][Full Text] [Related]
3. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
4. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
5. DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
Robertson CN; Paulson DF
Acta Oncol; 1991; 30(2):205-7. PubMed ID: 2029406
[TBL] [Abstract][Full Text] [Related]
6. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
8. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
9. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
10. In treating localized prostate cancer the efficacy of cryoablation is independent of DNA ploidy type.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
Technol Cancer Res Treat; 2004 Jun; 3(3):253-7. PubMed ID: 15161318
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
Badalament RA; O'Toole RV; Young DC; Drago JR
Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
[TBL] [Abstract][Full Text] [Related]
12. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
[TBL] [Abstract][Full Text] [Related]
14. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
15. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
[TBL] [Abstract][Full Text] [Related]
16. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
Lee SE; Currin SM; Paulson DF; Walther PJ
J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
[TBL] [Abstract][Full Text] [Related]
19. Ploidy status correlates with outcome in stage B prostate adenocarcinoma.
Tucci Júnior S; Blumenfeld W; Narayan P
Braz J Med Biol Res; 1994 Jan; 27(1):25-32. PubMed ID: 8173528
[TBL] [Abstract][Full Text] [Related]
20. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]